Table 2.
Testosterone correlation with clinical characteristics in male ARVC patients (N = 68)
| Variables | Spearman correlation (TT) | Spearman correlation (BT) | ||
|---|---|---|---|---|
| ρ | P value | ρ | P value | |
| Height (cm) | 0.315 | 0.013 | 0.327 | 0.010 |
| Weight (kg) | 0.125 | 0.343 | 0.112 | 0.393 |
| Body mass index (kg/m2) | 0.032 | 0.801 | 0.001 | 0.991 |
| Age (year) | −0.066 | 0.603 | −0.119 | 0.345 |
| Systolic pressure (mmHg) | 0.054 | 0.668 | 0.078 | 0.535 |
| Diastolic pressure (mmHg) | −0.030 | 0.815 | 0.001 | 0.995 |
| Heart rate (per min) | 0.082 | 0.518 | 0.110 | 0.381 |
| Age at onset of heart disease (year) | −0.157 | 0.230 | −0.209 | 0.108 |
| Age at onset of arrhythmia (year) | −0.050 | 0.717 | −0.142 | 0.307 |
| Length of drinking history (year) | 0.160 | 0.585 | 0.197 | 0.500 |
| Length of smoking history (year) | −0.062 | 0.800 | 0.066 | 0.789 |
| Number of precordial TWI | 0.032 | 0.855 | 0.185 | 0.287 |
| Number of precordial QRS fragmentation | 0.046 | 0.792 | 0.116 | 0.506 |
| LAID (mm) | −0.011 | 0.931 | 0.055 | 0.668 |
| IVS (mm) | −0.008 | 0.951 | 0.056 | 0.659 |
| LVEDD (mm) | −0.169 | 0.177 | −0.028 | 0.822 |
| LVEF (%) | 0.100 | 0.430 | 0.048 | 0.706 |
| RVEDD (mm) | 0.038 | 0.765 | −0.045 | 0.722 |
| RVEF (%) (by CMR) | −0.099 | 0.631 | −0.077 | 0.709 |
| Hb (g/L) | −0.091 | 0.490 | 0.112 | 0.396 |
| Albumin (g/L) | −0.141 | 0.269 | 0.001 | 0.998 |
| Glucose (mmol/L) | 0.020 | 0.879 | 0.078 | 0.550 |
| HbAlc (%) | −0.163 | 0.267 | −0.171 | 0.245 |
| AST (IU/L) | −0.005 | 0.971 | 0.057 | 0.660 |
| ALT (IU/L) | 0.016 | 0.905 | 0.073 | 0.571 |
| P (mmol/L) | 0.273 | 0.037 | 0.260 | 0.047 |
| Ca (mmol/L) | −0.074 | 0.578 | 0.048 | 0.716 |
| Creatinine (μmol/L) | −0.066 | 0.608 | −0.126 | 0.329 |
| BUN (mmol/L) | −0.050 | 0.702 | 0.055 | 0.671 |
| Triglyceride (mmol/L) | −0.001 | 0.992 | 0.092 | 0.486 |
| Cholesterol (mmol/L) | −0.194 | 0.134 | −0.041 | 0.756 |
| LDL‐Chol (mmol/L) | −0.153 | 0.248 | −0.070 | 0.599 |
| HDL‐Chol (mmol/L) | −0.100 | 0.457 | −0.045 | 0.737 |
| FFA (mmol/L) | 0.129 | 0.378 | 0.127 | 0.386 |
| LP(a) (mg/L) | −0.046 | 0.731 | −0.100 | 0.456 |
| Apo A1 (g/L) | −0.121 | 0.399 | −0.031 | 0.827 |
| cTnI (ng/mL) | −0.064 | 0.771 | 0.202 | 0.356 |
| Hs‐CRP (mg/L) | 0.147 | 0.261 | 0.207 | 0.113 |
| NT‐proBNP (pg/mL) | 0.122 | 0.367 | 0.131 | 0.333 |
ALT, alanine aminotransferase; ARVC, arrhythmogenic right ventricular cardiomyopathy; AST, aspartate aminotransferase; BT, bioavailable testosterone; BUN, blood urea nitrogen; Ca, blood calcium; cTnI, cardiac troponin I; FFA, free fatty acid; Hb, haemoglobin; HbAlc, glycosylated haemoglobin; HDL‐Chol, high density lipoprotein cholesterol; Hs‐CRP, high‐sensitivity C‐reactive protein; IVS, interventricular septal thickness; LAID, left atrium internal dimension; LDL‐Chol, low density lipoprotein cholesterol; LVEDD, left ventricular end‐diastolic diameter; LVEF, left ventricular ejection fraction; NT‐proBNP, N‐terminal pro‐brain natriuretic peptide; P, blood phosphorus; RVEDD, right ventricular end‐diastolic diameter; TT, total testosterone; TWI, T wave inversion.